Conference Call on Thursday, November 12, 2020 at 3:00 pm EST / 12:00 pm PST SAN FRANCISCO, CA, Nov. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – American Shared Hospital Services (NYSE American: AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy solutions, today announced… Read More..
- Confirmed overall response rate (ORR) of 21% in the Phase 1b dose-escalation stage across all doses, with 1 complete response and 3 partial responses - Confirmed ORR 33% at the highest and recommended Phase 2 dose - Durable and ongoing responses at the time of data analysis, with progression-free… Read More..
Clinical case reports and animal studies that were presented support the broad potential of AC5 Advanced Wound System in a range of complicated acute and chronic wounds FRAMINGHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and… Read More..